SC dismisses Sun Pharma's plea against NPPA's demand notice of Rs 4.65 cr for overcharging drugThe Supreme Court dismissed Sun Pharma's plea against a demand notice of Rs 4.65 crore by NPPA for overcharging for the drug Roscilox, upho...
Supreme Court upholds NPPA's Rs 4.65 cr recovery from Sun Pharma for drug price violationThe Supreme Court upheld NPPA's Rs 4.65 crore recovery from Sun Pharma for Roscilox overpricing (April 1996 - July 2003). The appeal was re...
Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price capPricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The ...
Government to bring major changes in Drug Pricing Control Order"We will have major reforms in DPCO, that I am going to assure. We need to have reforms in DPCO. We need to come out with a new pharma poli...
NPPA revises ceiling prices of 5 scheduled drug formulationsNPPA has been entrusted with the task of fixing and revising prices of pharma products, enforcement of provisions of DPCO and monitoring th...
Pharma companies air concerns over plans to cap pricesIf finalised, the regulator will be able to cap prices of several essential medicines, including those to treat poisoning, cardiovascular d...
NPPA issues notices to drug companies over violations of DPCO 2013NPPA has issued notices to major drug firms for failing to register products on online database IPDMS and not filing mandatory returns thro...
Drug price cut yielded Rs 2,772 crore benefit to public: GovernmentAll the NLEM 2011 medicines have been included in the first schedule of DPCO, 2013, and brought under price control.
NPPA exempts price controls for three insulins of WockhardtIndia’s drug pricing watchdog, the National Pharmaceutical Pricing Authority (NPPA), has exempt drug maker Wockhardt’s three insulin produc...
Prices of around 12,000 drug SKUs decline in January: NPPAPrices of around 12,000 stock keeping units (SKUs) of medicines have come down during January this year as a consequence of implementation ...
Decontrolling prices of cardiac, diabetes drugs challenged in SCUnder Drug Price Control Order 2013, the government already controls the prices of 348 drugs listed in the National List of Essential Medic...
80% of medicines not covered by price control orderThe much-awaited drug price control order (DPCO) 2013, meant to control the price of medicines does not cover over 80% of the medicines in ...
Pharma industry hit by worst slowdown in the domestic market for the month of AugustThe Indian pharma industry, while being on a roll due to the higher export realisations due to the weaker rupee, has suffered badly in the ...
Firms need to give 6 months notice to stop essential drugsThe government can ask the manufacturers to continue to produce required level of essential drugs, read Drug Price Control Order.
- State FDA may add more drugs to price control list
The list of drugs under the Drug Price Control Order (DPCO) could increase significantly, if the Maharashtra FDA has its way.
- Ready suit for DPCO bypassers
Drug makers planning to introduce new brands that contain price-controlled ingredients may face prosecution if they enter the market withou...
- NPPA to submit recommendations by end of the week
National Pharmaceutical Pricing Authority (NPPA) will submit its recommendations on the Drug Price Control Order (DPCO) 2002, based on the ...